2006
DOI: 10.1074/jbc.m505625200
|View full text |Cite
|
Sign up to set email alerts
|

Down-regulation of Endogenous Amyloid Precursor Protein Processing due to Cellular Aging

Abstract: Processing of amyloid precursor protein (APP) is a well acknowledged central pathogenic mechanism in Alzheimer disease. However, influences of age-associated cellular alterations on the biochemistry of APP processing have not been studied in molecular detail so far. Here, we report that processing of endogenous APP is down-regulated during the aging of normal human fibroblasts (IMR-90). The generation of intracellular APP cleavage products C99, C83, and AICD gradually declines with increasing life span and is … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
57
0

Year Published

2007
2007
2011
2011

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 66 publications
(60 citation statements)
references
References 56 publications
3
57
0
Order By: Relevance
“…However, with respect to the increased APP CTF␤-to-APP CTF␣ ratio, we infer that the drugs also stimulate the ␤-secretase cleavage of endogenous APP. To further extend the described effect on non-neuronal cells, we used the primary human fibroblasts cell line IMR-90, which was shown previously to be suitable for studying APP metabolism at the endogenous level (Kern et al, 2006). The experiments with this cell line mirrored the results obtained from N2a Swe cells and from N2a cells upon treatment with fenofibrate and celecoxib, including the accumulations of APP CTF␤ and full-length APP (Fig.…”
Section: Cox Inhibitors and Fibrates With Cholesterol-like Action 147mentioning
confidence: 95%
“…However, with respect to the increased APP CTF␤-to-APP CTF␣ ratio, we infer that the drugs also stimulate the ␤-secretase cleavage of endogenous APP. To further extend the described effect on non-neuronal cells, we used the primary human fibroblasts cell line IMR-90, which was shown previously to be suitable for studying APP metabolism at the endogenous level (Kern et al, 2006). The experiments with this cell line mirrored the results obtained from N2a Swe cells and from N2a cells upon treatment with fenofibrate and celecoxib, including the accumulations of APP CTF␤ and full-length APP (Fig.…”
Section: Cox Inhibitors and Fibrates With Cholesterol-like Action 147mentioning
confidence: 95%
“…To further demonstrate this phenomenon, we isolated the detergent-resistant membrane fractions on an OptiPrep density gradient. Previous studies have shown that using a similar method the lipid rafts migrate to the interface between the 5 and 30% OptiPrep layers (61). Under the conditions used in the experiments outlined here, this corresponds to fractions 3 and 4.…”
Section: Endocannabinoid-induced Effects On Apoptosis and Cellmentioning
confidence: 99%
“…ß-site amyloid cleavage enzyme (BACE) has two homologues, with BACE1 being the main ß-secretase in the brain and the first cleavage enzyme in the production of Aß (3,4). Recent evidence shows that the proteolytic processing of APP by ß-and Á-secretases is correlated with the process of aging (5).…”
Section: Introductionmentioning
confidence: 99%